Jadelle Sine Inserter

Levonorgestrel, the active ingredient in Jadelle Sine Inserter, is a progestogen presented as a subcutaneous implant for subcutaneous use. It provides long‑acting reversible contraception for women of reproductive age.

GNH USA supplies Jadelle Sine Inserter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levonorgestrel is used as a hormonal contraceptive to prevent unintended pregnancy. - Contraception: Provides continuous prevention of pregnancy for up to five years after insertion. - Family planning: Enables women to plan pregnancies with a reliable, low‑maintenance method. - Post‑abortion contraception: Allows immediate initiation of long‑term birth control following an abortion procedure.

Levonorgestrel implants may cause a range of adverse reactions.

Common Side Effects: - Irregular vaginal bleeding or spotting - Amenorrhea (absence of periods) - Headache - Acne or skin changes - Weight gain or mild fluid retention - Mood swings or depressive symptoms

Serious or Rare Side Effects: - Ectopic pregnancy if implantation occurs outside the uterus - Pelvic inflammatory disease - Insertion site infection or abscess - Device migration or expulsion - Severe allergic reaction (anaphylaxis) - Thromboembolic events (rare)

Before using Jadelle Sine Inserter, certain precautions should be observed. - Pregnancy testing: Confirm the patient is not pregnant prior to insertion. - Breastfeeding: Discuss potential risks and benefits with a healthcare professional. - Medication review: Evaluate concurrent drugs that may affect hormonal activity. - Medical history: Assess for clotting disorders, liver disease, or hormone‑sensitive cancers. - Follow‑up care: Schedule regular visits to check implant position and monitor side effects. - Store at ambient temperature: Keep in original packaging, protect from moisture and direct sunlight.

Levonorgestrel implants can interact with other medicines, requiring attention to avoid reduced efficacy or increased risk.

Major Interactions (Avoid): - Combined hormonal contraceptives: Concurrent use may increase hormonal load. - Enzyme‑inducing antiepileptics (e.g., carbamazepine, phenytoin): May lower contraceptive effectiveness. - Rifampin or other strong inducers: Can significantly reduce levonorgestrel levels.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., ketoconazole): May increase hormone concentrations. - Protease inhibitor antiretrovirals: May alter metabolism of levonorgestrel. - St. John’s wort (herbal supplement): Potentially decreases contraceptive efficacy.